PL3900711T3 - Wchłaniany przezskórnie preparat zawierający stabilizowany donepezil - Google Patents

Wchłaniany przezskórnie preparat zawierający stabilizowany donepezil

Info

Publication number
PL3900711T3
PL3900711T3 PL19897865.2T PL19897865T PL3900711T3 PL 3900711 T3 PL3900711 T3 PL 3900711T3 PL 19897865 T PL19897865 T PL 19897865T PL 3900711 T3 PL3900711 T3 PL 3900711T3
Authority
PL
Poland
Prior art keywords
donepezil
preparation containing
transdermal absorption
absorption preparation
containing stabilized
Prior art date
Application number
PL19897865.2T
Other languages
English (en)
Inventor
Sun-Woo Jang
Chang-Yell Shin
Hae-Sun Kim
Kwang-Ho Cha
Hyun-Jung Kim
Masaoki Goto
Original Assignee
Dong-A St Co., Ltd.
KM Transderm Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong-A St Co., Ltd., KM Transderm Ltd. filed Critical Dong-A St Co., Ltd.
Publication of PL3900711T3 publication Critical patent/PL3900711T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL19897865.2T 2018-12-21 2019-09-05 Wchłaniany przezskórnie preparat zawierający stabilizowany donepezil PL3900711T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180167289A KR102115102B1 (ko) 2018-12-21 2018-12-21 안정화된 도네페질 함유 경피 흡수제제
PCT/KR2019/011483 WO2020130287A1 (ko) 2018-12-21 2019-09-05 안정화된 도네페질 함유 경피 흡수제제

Publications (1)

Publication Number Publication Date
PL3900711T3 true PL3900711T3 (pl) 2024-07-22

Family

ID=70914737

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19897865.2T PL3900711T3 (pl) 2018-12-21 2019-09-05 Wchłaniany przezskórnie preparat zawierający stabilizowany donepezil

Country Status (16)

Country Link
US (1) US12168073B2 (pl)
EP (1) EP3900711B1 (pl)
JP (1) JP7193643B2 (pl)
KR (1) KR102115102B1 (pl)
CN (1) CN113260356B (pl)
AU (1) AU2019405846B2 (pl)
CA (1) CA3124070C (pl)
CL (1) CL2021001463A1 (pl)
ES (1) ES2972123T3 (pl)
MA (1) MA53418B1 (pl)
MX (1) MX2021007078A (pl)
PE (1) PE20211791A1 (pl)
PH (1) PH12021551453A1 (pl)
PL (1) PL3900711T3 (pl)
WO (1) WO2020130287A1 (pl)
ZA (1) ZA202104943B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102218593B1 (ko) * 2020-05-13 2021-02-22 동아에스티 주식회사 안정성이 향상된 도네페질 함유 경피 흡수제제
JP2022122784A (ja) * 2021-02-10 2022-08-23 コスメディ製薬株式会社 酸化防止剤含有経皮吸収製剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609727B2 (ja) * 1980-09-27 1985-03-12 日東電工株式会社 貼り付け用膏体
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US6372760B1 (en) 1999-03-31 2002-04-16 Eisai Co., Ltd. Stabilized composition comprising antidementia medicament
KR20050037405A (ko) 2001-10-17 2005-04-21 히사미쯔 제약 주식회사 경피 흡수형 제제
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20080138388A1 (en) 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
EP2098234A4 (en) 2006-12-01 2012-03-21 Nitto Denko Corp SKIN ADHESIVE PREPARATION COMPRISING DERESZEZIL STABILIZED
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
KR101408488B1 (ko) 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
EP2638906A1 (en) * 2006-12-01 2013-09-18 Nitto Denko Corporation Stabilized adhesive preparation containing donepezil
KR101454362B1 (ko) 2008-03-24 2014-10-23 아이큐어 주식회사 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제
US20090291127A1 (en) 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
AU2010309030B2 (en) 2009-10-21 2013-10-31 Teikoku Seiyaku Co., Ltd. Transdermally absorbable donepezil-containing preparation
CN102614109B (zh) * 2012-04-16 2013-11-13 上海现代药物制剂工程研究中心有限公司 基于多层液晶骨架的、含有活性物质的凝胶组合物及制法
KR101770675B1 (ko) 2013-01-30 2017-08-23 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
KR101485822B1 (ko) 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
KR20160120778A (ko) 2014-02-20 2016-10-18 날 파마슈티칼 그룹 리미티드 도네페질을 함유하는 경피흡수제제
CN106714787A (zh) * 2014-09-25 2017-05-24 富士胶片株式会社 含丙泊酚的水包油型乳液组合物及其制造方法
PT3235494T (pt) 2014-12-18 2020-03-05 Icure Pharm Inc Preparação transdérmica contendo donepezilo como ingrediente ativo
WO2017073516A1 (ja) * 2015-10-26 2017-05-04 久光製薬株式会社 貼付剤
US20180008612A1 (en) 2016-07-11 2018-01-11 Taho Pharmaceuticals Ltd. Transdermal delivery system containing galantamine or salts thereof
JP7071330B2 (ja) 2016-07-27 2022-05-18 コリウム, インコーポレイテッド 炭酸水素ナトリウムのin situ変換で促進されたアミン薬物の経皮送達
KR102024996B1 (ko) 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
US12582637B2 (en) 2018-08-31 2026-03-24 Arctic Therapeutics Hf Topical formulation for intradermal application and uses thereof

Also Published As

Publication number Publication date
CN113260356B (zh) 2024-09-17
EP3900711A4 (en) 2022-11-30
JP7193643B2 (ja) 2022-12-20
ES2972123T3 (es) 2024-06-11
BR112021012142A2 (pt) 2021-09-08
KR102115102B1 (ko) 2020-05-26
CA3124070C (en) 2024-03-12
MA53418B1 (fr) 2023-03-31
MX2021007078A (es) 2021-09-10
JP2022514037A (ja) 2022-02-09
US20220047524A1 (en) 2022-02-17
AU2019405846B2 (en) 2022-10-20
ZA202104943B (en) 2022-08-31
EP3900711A1 (en) 2021-10-27
MA53418A1 (fr) 2022-08-31
CL2021001463A1 (es) 2021-12-10
EP3900711B1 (en) 2024-03-06
WO2020130287A1 (ko) 2020-06-25
PH12021551453A1 (en) 2022-04-18
CN113260356A (zh) 2021-08-13
AU2019405846A1 (en) 2021-06-17
US12168073B2 (en) 2024-12-17
PE20211791A1 (es) 2021-09-09
EP3900711C0 (en) 2024-03-06
CA3124070A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
IL267402A (en) A sheet containing nicotine
IL265752A (en) Spirocyclic compounds
GB201616839D0 (en) Therapeutic compounds
HUE048569T2 (hu) Hatóanyagként donepezilt tartalmazó transzdermális készítmény
PL3135287T3 (pl) Preparat zawierający związek tetracykliczny w dużej dawce
IL254662A0 (en) Spirocyclic compounds
GB201601703D0 (en) Therapeutic compounds
HUE059926T2 (hu) Többkomponensû, biztonsági tûvédõ kupak
IL273087A (en) Transdermal compositions
EP3266494A4 (en) Transdermal absorption sheet
PL3391884T3 (pl) Preparat do wchłaniania przezskórnego
GB201617339D0 (en) Therapeutic compounds
SG11201702334SA (en) External preparation composition containing s-flurbiprofen
ZA202104943B (en) Percutaneous absorption preparation comprising stabilized donepezil
HUE052269T2 (hu) NRF2-t aktiváló vegyületek és alkalmazásuk
PL3411368T3 (pl) Związki aktywujące nrf2 i ich zastosowania
IL263821A (en) Medicinal compounds
ZA201802565B (en) New adjuvant and vaccine composition containing the same
IL258675A (en) Mosquito repellent compounds
GB201617221D0 (en) Sunscreen composition
IL272467A (en) Novel compounds that activate the NRF2 pathway
GB201607548D0 (en) Solid dosage form
EP3284484A4 (en) Transdermal preparation containing antifungal active material
EP3299012A4 (en) Transdermal liquid preparation
EP3441068A4 (en) TRANSDERMALES PREPARATION